Table 2 Multivariable adjusted hazard ratios for overall mortality by pre-diagnostic lipids and breast cancer molecular subtypes

 Continuous, mmol/l

464

1.01 (0.88–1.22)

228

0.99 (0.56–1.75)

99

1.64 (0.78–3.46)

43

0.06 (0.01–0.77)

94

1.02 (0.83–1.24)

  ≤ 0.82 mmol/l

153

1.00

77

1.00

33

1.00

14

1.00

29

1.00

 0.83–1.22 mmol/l

158

0.69 (0.42–1.11)

78

1.19 (0.53–2.66)

33

0.50 (0.17–1.46)

14

0.13 (0.03–0.64)

33

0.96 (0.35–2.62)

  ≥ 1.23 mmol/l

153

1.24 (0.78–1.99)

73

1.26 (0.57–2.78)

33

1.01 (0.36–2.78)

15

0.06 (0.01–0.55)

32

2.99 (1.17–7.63)

p-trend

0.351

0.838

0.179

0.001

0.011

Continuous, mmol/l

464

1.03 (0.90–1.19)

228

1.06 (0.83–1.36)

99

1.00 (0.66–1.51)

43

1.05 (0.70–1.57)

94

1.05 (0.77–1.44)

  ≤ 5.14 mmol/l

155

1.00

77

1.00

37

1.00

11

1.00

30

1.00

 5.15–6.25 mmol/l

156

1.33 (0.80–2.22)

82

1.66 (0.70–3.95)

27

0.85 (0.29–2.50)

16

1.28 (0.18–7.93)

31

1.01 (0.39–2.67)

  ≥ 6.26 mmol/l

153

1.46 (0.87–2.44)

69

1.48 (0.61–3.60)

35

1.20 (0.38–3.72)

16

2.04 (0.34–12.3)

33

1.41 (0.49–4.06)

p-trend

0.354

0.512

0.830

0.533

0.731

Continuous,

464

0.89 (0.58–1.36)

228

0.68 (0.02–25.0)

99

0.23 (0.01–54.2)

43

693 (0.06–747)

94

0.02 (0.00–1.39)

  ≤ 0.27

154

1.00

76

1.00

32

1.00

21

1.00

25

1.00

 0.28–0.34

154

0.84 (0.65–1.29)

67

0.81 (0.37–1.79)

37

1.48 (0.57–3.87)

14

1.53 (0.45–5.23)

36

0.53 (0.24–1.19)

  ≥ 0.35

156

0.82 (0.51–1.33)

85

1.05 (0.43–2.00)

30

0.96 (0.33–2.74)

8

5.61 (0.62–21.0)

33

0.33 (0.12–0.89)

p-trend

0.385

0.819

0.986

0.176

0.026